Terms: = Cervical cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC
5 results:
1. Impact of Polymorphism in Base Excision Repair and Nucleotide Excision Repair Genes and Risk of cervical cancer: A Case-Control Study.
Datkhile KD; Durgawale PP; Patil MN; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1291-1300. PubMed ID: 35485688
[TBL] [Abstract] [Full Text] [Related]
2. MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway.
Fang C; Chen YX; Wu NY; Yin JY; Li XP; Huang HS; Zhang W; Zhou HH; Liu ZQ
Sci Rep; 2017 Jan; 7():40384. PubMed ID: 28074905
[TBL] [Abstract] [Full Text] [Related]
3. Genetic variants of DNA repair gene xpc modulating susceptibility to cervical cancer in North India.
Gangwar R; Mittal B; Srivastava S; Singh H; Mittal RD
Oncol Res; 2010; 18(7):329-35. PubMed ID: 20377134
[TBL] [Abstract] [Full Text] [Related]
4. Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome.
Klopp AH; Jhingran A; Ramdas L; Story MD; Broadus RR; Lu KH; Eifel PJ; Buchholz TA
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):226-36. PubMed ID: 18406887
[TBL] [Abstract] [Full Text] [Related]
5. Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients.
Saldivar JS; Lu KH; Liang D; Gu J; Huang M; Vlastos AT; Follen M; Wu X
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S223-9. PubMed ID: 17825393
[TBL] [Abstract] [Full Text] [Related]
